• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Reprod Immunol . Association Between Influenza Vaccination and SARS-CoV-2 Infection

tetano

Editor, Senior Moderator
Am J Reprod Immunol


. 2024 Jul;92(1):e13896.
doi: 10.1111/aji.13896. Association Between Influenza Vaccination and SARS-CoV-2 Infection

Marwan Ma'ayeh[SUP] 1 [/SUP], Jessica A de Voest[SUP] 2 [/SUP], Brenna L Hughes[SUP] 3 [/SUP], William A Grobman[SUP] 4 [/SUP], George R Saade[SUP] 5 [/SUP], Tracy A Manuck[SUP] 3 [/SUP], Monica Longo[SUP] 6 [/SUP], Hyagriv N Simhan[SUP] 7 [/SUP], Dwight J Rouse[SUP] 8 [/SUP], Hector Mendez-Figueroa[SUP] 9 [/SUP], Cynthia Gyamfi-Bannerman[SUP] 10 [/SUP], Jennifer L Bailit[SUP] 11 [/SUP], Maged M Costantine[SUP] 1 [/SUP], Harish M Sehdev[SUP] 12 [/SUP], Alan T N Tita[SUP] 13 [/SUP], Torri D Metz[SUP] 14 [/SUP]; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal‐Fetal Medicine Units (MFMU) Network



Affiliations
Abstract

Background: Recent data in nonpregnant individuals suggest a protective effect of influenza vaccination against SARS-CoV-2 infection and its severity.
Objectives: Our primary objective was to evaluate whether influenza vaccination was associated with COVID-19 severity and pregnancy and neonatal outcomes among those infected with SARS-CoV-2. The secondary objective was to examine the association between influenza vaccination and SARS-CoV-2 infection.
Study design: Secondary analysis of a multicenter retrospective cohort of pregnant people who tested positive for SARS-CoV-2 between March and August 2020, and a cohort of random deliveries during the same time period. The associations between 2019 influenza vaccination and the primary outcome of moderate-to-critical COVID-19 as well as maternal and perinatal outcomes were examined among all people who tested positive for SARS-CoV-2 between March and August 2020. The association between 2019 influenza vaccination and having a positive SARS-CoV-2 test was examined among a cohort of individuals who delivered on randomly selected dates between March and August 2020. Univariable and multivariable analyses were performed.
Results: Of 2325 people who tested positive for SARS-CoV-2, 1068 (45.9%) were vaccinated against influenza in 2019. Those who received the influenza vaccine were older, leaner, more likely to have private insurance, and identify as White or Hispanic. They were less likely to smoke tobacco and identify as Black. Overall, 419 (18.0%) had moderate, 193 (8.3%) severe, and 52 (2.2%) critical COVID-19. There was no association between influenza vaccination and moderate-to-critical COVID-19 (29.2% vs. 28.0%, adjusted OR 1.10, 95% CI 0.90-1.34) or adverse maternal and perinatal outcomes among those who tested positive. Of 8152 people who delivered in 2020, 4658 (57.1%) received the influenza vaccine. Prior vaccination was not associated with a difference in the odds of SARS-CoV-2 infection (3.8% vs. 4.2%, adjusted OR 0.94, 95% CI 0.74-1.19).
Conclusion: Prior influenza vaccination was not associated with decreased severity of COVID-19 or lower odds of SARS-CoV-2 infection in pregnancy.

Keywords: COVID‐19; SARS‐CoV‐2; coronavirus; disease; infection; influenza; pregnancy.

 
Back
Top Bottom